Fund Holdings — SECTOR GAMMA AS

Total Portfolio Value:
$312.19M
Total Bought:
$62.54M
Total Sold:
$50.16M
Net Transaction:
+$12.38M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)366,166435,000+68,834$20.71M$26.53M8.50%+$5.82M
Pfizer Inc.(PFE)1,155,000925,000-230,000$30.64M$23.44M7.51%-$7.20M
Becton, Dickinson and Company(BDX)76,00082,000+6,000$17.24M$18.78M6.02%+$1.54M
Medtronic plcSHS(MDT)320,000205,000-115,000$25.56M$18.42M5.90%-$7.14M
Amgen Inc.(AMGN)46,00059,000+13,000$11.99M$18.38M5.89%+$6.39M
Johnson & Johnson(JNJ)78,00098,000+20,000$11.28M$16.25M5.21%+$4.97M
Gilead Sciences, Inc.(GILD)197,500140,000-57,500$18.24M$15.69M5.02%-$2.56M
CVS Health Corporation(CVS)217,000202,000-15,000$9.74M$13.69M4.38%+$3.94M
Zimmer Biomet Holdings, Inc.(ZBH)137,714113,631-24,083$14.55M$12.86M4.12%-$1.69M
Elevance Health, Inc.(ELV)17,27928,779+11,500$6.37M$12.52M4.01%+$6.14M
Cardinal Health, Inc.(CAH)88,00088,0000$10.41M$12.12M3.88%+$1.72M
Centene Corporation(CNC)170,000177,000+7,000$10.30M$10.75M3.44%+$447.1K
BioMarin Pharmaceutical Inc.(BMRN)217,348137,348-80,000$14.29M$9.71M3.11%-$4.58M
Incyte Corporation(INCY)197,400159,000-38,400$13.63M$9.63M3.08%-$4.01M
Edwards Lifesciences Corp99,000123,000+24,000$7.33M$8.92M2.86%+$1.59M
Bruker Corporation(BRKR)158,970211,970+53,000$9.32M$8.85M2.83%-$471.2K
Ionis Pharmaceuticals, Inc.(IONS)235,842285,842+50,000$8.25M$8.62M2.76%+$378.8K
Baxter Intl Inc158,650247,650+89,000$4.63M$8.48M2.72%+$3.85M
Qiagen N.V.(QGEN)0187,000+187,000$0$7.51M2.40%+$7.51M
Humana Inc.(HUM)14,00025,000+11,000$3.55M$6.62M2.12%+$3.06M
Tenet Healthcare Corporation(THC)22,00043,000+21,000$2.78M$5.78M1.85%+$3.01M
Elanco Animal Health Incorporated(ELAN)276,907477,073+200,166$3.35M$5.01M1.60%+$1.66M
GE HealthCare Technologies Inc.(GEHC)50,00062,000+12,000$3.91M$5.00M1.60%+$1.10M
PTC Therapeutics, Inc.(PTCT)65,25092,250+27,000$2.95M$4.70M1.51%+$1.76M
Tandem Diabetes Care, Inc.(TNDM)0180,523+180,523$0$3.46M1.11%+$3.46M
Bio Rad Labs IncCL A16,82913,829-3,000$5.53M$3.37M1.08%-$2.16M
BioNTech SEADR(BNTX)40,00030,000-10,000$4.56M$2.73M0.88%-$1.83M
Ascendis Pharma A/SADR(ASND)017,000+17,000$0$2.65M0.85%+$2.65M
Biogen Inc.(BIIB)29,00018,639-10,361$4.43M$2.55M0.82%-$1.88M
Lantheus Holdings, Inc.(LNTH)25,71225,000-712$2.30M$2.44M0.78%+$139.8K
Arcellx Inc
COMMON STOCK
035,000+35,000$0$2.30M0.74%+$2.30M
Solventum Corporation(SOLV)030,000+30,000$0$2.28M0.73%+$2.28M
TG Therapeutics, Inc.(TGTX)055,000+55,000$0$2.17M0.69%+$2.17M
Legend Biotech CorporationADS(LEGN)48,4950-48,495$1.58M$0—-$1.58M
Qiagen N.V.SHS NEW(QGEN)203,9930-203,993$9.08M$0—-$9.08M
Tandem Diabetes Care Inc66,0230-66,023$2.38M$0—-$2.38M
Page 1 of 1
SECTOR GAMMA AS — 13F Holdings — Q1 2025 | TickerTrail